Evidence map›Paper›PMID 42601380›Full record

ArticleScientific reports2026

Topological indices and QSPR analysis of drug molecules from different therapeutic classes.

Zeeshan Saleem Mufti, Umm E Rubab, Aiedh Mrisi Alharthi, Gamachu Adugna Ganati

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zeeshan Saleem MuftiDepartment of Mathematics and Statistics, The University of Lahore, Lahore, Pakistan.
Umm E RubabDepartment of Mathematics and Statistics, The University of Lahore, Lahore, Pakistan.
Aiedh Mrisi AlharthiDepartment of Mathematics, Turabah University College, Taif University, Taif, Saudi Arabia.
Gamachu Adugna GanatiDepartment of Mathematics, Wallaga University, Nekemte, Ethiopia. gammeekoo@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Typically, Quantitative Structure-Property Relationship (QSPR) models are created for compounds related to a particular therapeutic use and might be restricted in scope. To explore the wider use of neighbourhood connectivity descriptors, ten drug molecules, encompassing a wide range of chemical and therapeutic classes, were chosen: anti-inflammatory, anti-bacterial, anti-viral, anti-hypertensive, anesthetic, anti-depressant and neuromuscular agents. The molecular structures were represented as graphs, with atoms represented by the vertices and chemical bonds represented by the edges, and various neighbourhood degree-based topological indices were calculated. Linear, quadratic and cubic QSPR regression models were used to correlate these descriptors with nine experimentally determined physicochemical properties such as boiling point, density, enthalpy of vaporization, flash point, refractive index, molar refractivity, polarizability, surface tension and molar volume. The coefficient of determination ([Formula: see text]) was used to evaluate the model performance. The results show that neighbourhood-based descriptors are able to capture molecular structural information and make reliable prediction of properties on structurally diverse drug molecules. The results provide good justification to use these descriptors in general for chemical graph theory and in QSPR studies without any particular disease or therapeutic indication.

Indexed as

Quantitative Structure-Activity RelationshipModels, MolecularMolecular StructurePharmaceutical PreparationsPharmaceutical PreparationsChemical graph theoryDrug molecular structuresNeighborhood based topological indicesQuantitative structure–property relationship (QSPR)Regression modeling

Identifiers

PMID42601380
PMCPMC13476439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.